Standard Dosing Schedule for Prolia in Osteoporosis
Prolia (denosumab) is given as a 60 mg subcutaneous injection every 6 months for postmenopausal women with osteoporosis at high risk for fracture, or for men with osteoporosis at increased risk of fracture.[1][2]
Who Qualifies and How It's Administered
Treatment targets patients with a history of osteoporotic fracture, multiple risk factors for fracture, or those who have failed or cannot tolerate other osteoporosis drugs. The injection is typically done in a doctor's office, using a pre-filled syringe in the thigh, abdomen, or upper arm.[1][3]
What Happens If You Miss a Dose
Administer the missed dose as soon as possible, then resume the 6-month schedule. If the delay exceeds 6 months from the last dose, consult a doctor to assess risks like increased fracture potential.[1]
Duration of Treatment
Prolia is intended for long-term use, but doctors reassess periodically due to risks like jaw osteonecrosis or atypical femur fractures with prolonged therapy. No fixed endpoint exists; stopping requires transition to another agent to prevent rebound bone loss.[2][4]
Why Every 6 Months Instead of More Often
Denosumab inhibits RANKL, a protein driving bone breakdown, providing sustained effects for up to 6 months per dose, unlike weekly or monthly bisphosphonates.[3]
Prolia vs. Other Osteoporosis Treatments
| Treatment | Frequency | Key Difference |
|-----------|-----------|---------------|
| Prolia | Every 6 months (injection) | Targets RANKL for broader bone protection; higher adherence due to fewer doses. |
| Fosamax (alendronate) | Weekly (oral) | Bisphosphonate; GI side effects common. |
| Reclast (zoledronic acid) | Yearly (IV infusion) | Similar potency but annual dosing. |
| Forteo (teriparatide) | Daily (injection) | Anabolic; daily self-injection limits convenience. |[1][2][5]
Common Patient Concerns with Dosing
Patients often ask about injection site pain (mild, temporary) or travel logistics for biannual visits. Calcium and vitamin D supplements are required daily to support treatment.[1][3]
[1]: Prolia Prescribing Information (Amgen)
[2]: FDA Label for Prolia
[3]: American College of Rheumatology Guidelines on Osteoporosis
[4]: NOF Clinician's Guide to Prevention and Treatment of Osteoporosis
[5]: DrugPatentWatch.com - Prolia Patent Status